|
1 Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA, 1996，93(6)：2239－2244.
|
|
2 Gebel HM, Braun DP, Tambur A, et al. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril, 1998, 69(6)：1042－1047.
|
|
3 Meresman GF, Vighi S, Buquet RA, et al. Apoptosis and expression of Bcl－2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril, 2000, 74(4)：760－766.
|
|
4 Suganuma N, Harada M, Furuhashi M, et al. Apoptosis in human endometrial and endometriotic tissues. Horm Res, 1997, 48(Suppl 3)：42－47.
|
|
5 McLaren J, Prentice A, Charnock－Jones DS, et al. Immunolocalization of the apoptosis regulationg ptotein Bcl－2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod, 1997，12(1)：146－152.
|
|
6 Gaetje R, Kotzian S, Herrmann G, et al. Invasiveness of endometriotic cells in vitro. Lancet, 1995, 346(8988)：1643－1644.
|
|
7 Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti－apoptosis gene survivin in human and mouse differentiation. Am J Pathol, 1998, 152(1)：43－49.
|
|
8 Conway EM, Pollefeyt S, Cornelissen J, et al. Three differentially expressed survivin c－DNA variants encoded proteins with distinct antiapoptotic functions. Blood, 2000, 95(4)：1435－1442.
|
|
9 Jiang X, Wilford C, Duensing S, et al. Participation of survivin in mitotic and apoptotic activities of normal and tumor－derived cells. J Cell Biochem, 2001, 83(2)：342－354.
|
|
10 Petersen J, Hagan IM. Spombe aurora kinase/survivin is required for chromosome condensation and the spindle checkpoint attachment response. Curr Biol, 2003, 13(7)：590.
|
|
11 Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist fas－mediated cell death. Oncogene, 2000，19(10)：1346－1353.
|
|
12 Grossman D, Kim PJ, Blanc－Brude OP, et al. Transgenic expression of survivin in keratinocytes counteracts UVB－induced apoptosis and cooperates with loss of p53. J Clin Invest, 2001, 108(7)：991－999.
|
|
13 Choi KS, Lee TH, Jung MH, et al. Ribozyme－mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF－7 cells. Cancer Gene Ther, 2003, 10(2)：87－95.
|
|
14 O'Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA, 2000, 97(24)：13103－13107.
|
|
15 Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell, 2002, 9(3)：459－470.
|
|
16 Ueda M, Yamashita Y, Takehara M, et al. Survivin gene expression in endometriosis. J Clin Endocrinol Metab, 2002, 87(7)：3452.
|
|
17 Takai N, Miyazaki T, Nishida M, et al. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett, 2002, 184(1)：105－116.
|
|
18 Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.Clin Cancer Res, 2000, 6(1)：127－134.
|
|
19 Ito T, Shiraki K, Sugimoto K, et al. Survivin promoted cell proliferation in human hepatocellular carcinoma. Hepatology, 2000, 31(5)：1080－1085.
|
|
20 Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer：Correlation with the prognosis and response to chemotherapy. Int J Cancer, 2001, 95(2)：92－95.
|